2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, David J. Cutter et al.|European Heart Journal|2022Cited by 2.7k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal - Cardiovascular Imaging|2022Cited by 486
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditisJohn R. Power, Ellen Warner, Joachim Alexandre et al.|Archives of cardiovascular diseases|2022Cited by 38
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R. Power, Anju Nohria, Charles Dolladille et al.|European Heart Journal|2025Cited by 34
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor MyocarditisJohn R. Power, Joe‐Elie Salem, Joachim Alexandre et al.|medRxiv|2021Cited by 14